Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2011

Jul 27, 2011

35124_dirs_2011-07-27_a4ff9af7-62b3-4b94-b344-b9f8f45b496d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-07-25

Reporting Person: LINK MAX (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-07-25 Celsion Corporation Common Stock P 46838 $4.27 Acquired 243942 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-07-25 Warrant to Purchase Common Stock $4.22 P 18735 Acquired 2016-07-25 Celsion Corporation Common Stock (18735) Direct

Footnotes

F1: The securities were purchased in a private placement transaction (the "Private Placement") completed July 25, 2011 between Celsion Corporation and qualified institutional investors as well as a director of Celsion Corporation.

F2: In the Private Placement, the Company sold units, each consisting of one share of the Company's common stock and a warrant to purchase 0.40 shares of the Company's common stock, at a price of $4.27 per unit.